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Abstract 
Background: There are two leading hypotheses that 
explain how social networks influence chronic diseases, 
such as depression. The “main effects hypothesis” 
describes a direct relationship between social support 
and depressive symptoms. The “stress- buffering 
hypothesis” posits that inadequate social support and life 
events increase the risk of disease outcomes. Insufficient 
social support is believed to be expressed through 
physiological changes (e.g., inflammation) that lead to 
the development of depression and other chronic 
conditions. The objective of this study was to 
empirically test these two leading hypotheses among 
cancer survivors and older adults without cancer and to 
explore the intermediate pathways between social 
support, chronic inflammation, and depressive 
symptoms. 
Method: A secondary analysis of two waves of data 
(2005-2011) from the National Social Life, Health, and 
Aging Project (NSHAP) was used to test the hypotheses 
of interest (n=698). Depressive symptoms were 
measured with the 11-item Iowa version of the CES-D. 
Inflammation was measured by C-reactive protein 
(CRP), Tumor necrosis factor-alpha (TNF-α), and 
Vascular Endothelial Growth Factor (VEGF). Social 
support was assessed with six items measuring 
emotional and tangible support. Structural equation 
models were used to assess direct and indirect paths 
between social support, inflammation, and depressive 
symptoms. 
 Results: Cancer survivors and older adults without a 
history of cancer were similar in terms of their 
depressive symptoms, inflammatory levels and social 
support over time. A significant negative direct effect 
was observed between the total amount of social support 
in Wave 2 (W2) and depressive symptoms in W2 
(p=0.01). No differences between cancer survivors and 
older adults without cancer were observed in path 
models and no indirect paths between social support, 
inflammation, and depressive symptoms were 
statistically significant in either group. 
Discussion: The results support the main effects 
hypothesis, whereby social networks directly influence 
depressive symptoms. Clinicians should consider 
screening for social support to prevent or reduce 
depressive symptomatology. 
 
Keywords: social support, inflammation, 
depressive symptoms, cancer survivors  
 
Background 
Cancer survivors are at risk for depressive 
symptoms in the United States. Approximately 
14% of cancer survivors in 2010 self-reported 
current depression compared to 9% of those 
without a history of cancer (61). The prevalence of 
depression varies by primary cancer site with lung, 
gynecological, and hematological cancer survivors 
reporting the highest levels of depression at the 
time of cancer diagnosis (62). Variation in the 
prevalence estimates also exists between studies. 
For example, studies among breas t cancer 
survivors report prevalence estimates ranging from 
1% to as high as 56% (63). Despite this variation, 
the consistently high occurrence of depressive 
symptoms in this population underscores the need 
to understand the potential pathways that place 
cancer survivors at risk for poor mental health 
outcomes. 
1. Social Networks and Depression 
Two prominent frameworks, the “main 
effects hypothesis” and the “stress - buffering 
hypothesis,” have emerged to describe how social 
support gets “under the skin” (64–66). The “main 
effects” hypothesis posits that social support 
directly contributes to health via the perception of 
help from peers and social influence on health 
behaviors, ideas, and emotions, irrespective of 
existing levels of support or experiencing stres sful 
life events, such as cancer (64, 66). The perception 
of adequate social support from the network 
members may directly improve health outcomes, 
while inadequate support may lead to poor to 
health outcomes (7). Among cancer survivors, low 
social support is associated with higher depressive 
symptomatology (67,68) and is predictive of the 
development of depression (10–12). However, few 
studies have considered how alterations in social 
support from life events, such as cancer, directly 
impact psychosocial well-being. 
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Disparities in social structures (e.g., 
policies, norms, etc.), interpersonal relations, 
including negative social interactions, and 
individual risk factors (e.g., economic position, 
demographics, etc.) are expressed through 
biological pathways. The “stress- buffering 
hypothesis” posits that socially supported 
individuals are safeguarded against physiological 
responses to acute and chronic stressors, ultimately 
protecting them from the development of disease 
downstream (64,65). Stressors activate the immune 
response in ways that elevate systemic levels of 
inflammation (e.g., pro-inflammatory cytokines 
such as, tumor necrosis factor-alpha (TNF-α) (72). 
Instable or low social support over time may be 
perceived as a continuously stressful situation and 
may result in sustained levels of chronic, low-
grade inflammation (65). Chronic inflammation 
can create an ideal tumor promoting environment 
(13,73) where tumor initiation, progression, 
angiogenesis, and metastasis can occur (13). This 
is especially important for cancer survivors, as 
deleterious physiological changes may lead to 
inequities in cancer recurrence (74). Moreover, 
inflammation is related to aging (75), the 
development of depressive symptoms, and 
atherosclerosis (72). Therefore, cancer survivors 
may be at an increased risk of inflammation-
related comorbidities, including depression (55), 
compared to the general older adult population. 
Previous studies have established a robust 
link between elevated inflammation and depression 
in both clinically depressed (76) and community 
samples (77). The relationship between 
inflammation and depression is bi-directional (78), 
as depressed individuals exhibit a larger 
inflammatory response to stressors (76,79) and 
medication- induced inflammation can result in the 
manifestation of depressive symptoms (77). 
Previous studies provide mixed evidence for an 
association between immune functioning and 
social network components in the general adult 
population (25, 54,31–34,80), and among cancer 
survivors (47, 69,35–39). However, several studies 
demonstrate beneficial effects when social 
networks are adequate and elevated levels of 
inflammation when they are inadequate. For 
example, an experimental study demonstrated that 
participants who perceived negative social 
situations with their partner, friends, and family 
had higher Interleukin-6 (IL-6) and TNF-α 
responses over time and demonstrated worse stress 
tolerance (81). In a longitudinal population-based 
study, Yang et al., (2014) observed that social 
strain was positively associated with C-reactive 
protein (CRP) and 
IL-6 and that social support were negatively 
associated with CRP and IL-6 (48). Glei et al. 
(2012) found that higher social support was 
associated with higher CRP (34) and Ford et al. 
(2006) showed that higher social network index 
scores were associated with elevated CRP in older 
men (aged >60) (32). Similarly, in a qualitative 
review of cancer survivors, Penwell and Larkin 
(2010) noted that the majority of studies (5/7) 
supported a positive association between social 
support and inflammation (25). 
Collectively, the literature provides 
evidence for direct relationships between social 
support and inflammation, social networks and 
depressive symptoms, and depressive symptoms 
and inflammation. However, no studies have 
formally tested inflammation as an intermediate 
pathway. The objective of this study was to 
empirically test the main effects and stress -
buffering model in a population of older adults, 
who either did or did not report a history of cancer 
(Figure 1). Specifically, our aims are threefold: 1) 
to assess the main affects hypothesis by directly 
testing the role of social support and depressive 
symptomatology; 2) to test the stress -buffering 
hypothesis by assessing the relationship between 
social support and depressive symptoms; and 3) to 
investigate three markers of inflammation (TNF-α, 
CRP, and Vascular Endothelial Growth Factor 
(VEGF)) as potential intermediate pathways to 
elucidate the mechanisms by which social support 
influences depressive symptoms. Support for a 
main effects hypothesis would be indicated by no 
group differences between cancer survivors and 
older adults without cancer. More pronounced 
relationships between social support and 
depressive symptoms, as well as significant 
intermediate paths between social support, 
inflammation, and depressive symptoms among 
cancer survivors would provide evidence for the 
stress-buffering hypothesis. 
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Figure 1. Hypothesized relations between social support, inflammation, and depression  
 
Methods 
2. Study Population 
A sample of 2,261 older adults between 
the ages of 57-85 participated in two waves of data 
collection (Wave 1 (W1): 2005-2006, Wave 2 
(W2): 2010-2011) by the National Social Life, 
Health, and Aging Project (NSHAP) (12, 57). 
Cancer survivorship was defined by individuals 
who self-reported a diagnosis of cancer (excluding 
skin cancers such as, melanoma, basal cell 
carcinoma, and squamous cell carcinoma) on the 
W1 questionnaire. Participants who self-reported a 
history of cancer for the first time in W2 were 
excluded, since their social support networks 
would not reflect their cancer diagnosis in W1 
(n=148). In accordance with the American Heart 
Association and the CDC guidelines, participants 
with CRP levels greater than 10 (an indication of 
acute infection) were excluded from the analysis 
because the present study is focused on chronic, 
low-grade inflammation (n=160) (49). We 
conducted a complete case analysis and excluded 
individuals with out of range biomarker data or 
who were missing at least one inflammatory 
marker (n=1,226). Missing data on social support 
(n=1) and covariates (n=28) was also excluded. 
There was no missing data for depressive 
symptoms. Our final sample consisted of 698 
individuals, of whom 90 reported a history of 
cancer. 
3. Measures 
Depressive symptoms 
Depressive symptoms was measured 
during the W1 and W2 home interview and was 
assessed using the 11-item Iowa short-form version 
of the Center for Epidemiologic Studies 
Depression (CES-D) Scale (82). The Iowa version 
of the CES-D has been previously validated and 
shown to exhibit the same dimensions as the 20-
item CES-D, while losing little precision (83). 
Each respondent was asked to report how often in 
the past week they felt depressed, like everything 
was an effort, sad, etc... Response options included 
0= “rarely or none of the time”, 1= “some of the 
time”, 2= “occasionally”, and 3= “most of the 
time.” Two items „felt happy‟ and „enjoyed life‟ 
were reverse coded to be consistent with the other 
items. The Iowa short form does not diagnose 
clinical depression, but rather, is a scale of 
depressive symptomatology. For the path analysis, 
all items were summed with higher scores 
indicating higher levels of depressive symptoms. 
For the latent variable model each scale item was 
used to measure the underlying construct of 
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depression. The Cronbach‟s alpha for the NSHAP 
sample was 0.80 in W1 and 0.79 in W2. 
Social Support 
 
Social support questions were adapted 
from Schuster et al. (1990) (184). 
Participants were asked in each wave of 
data collection to report how often they could 1) 
open up to, and 2) rely on their spouse/partner, 
family, and friends, for a total of six questions. 
Responses were measured on a three-point scale 
ranging from 0= “hardly ever or never” to 2= 
“often.” The six social support questions were 
summed to calculate the total amount of support 
received, with higher scores indicating more 
perceived social support for path models. For the 
latent variable model each scale item was used to 
measure the underlying construct of social support. 
Inflammation 
Three inflammatory markers previously 
associated angiogenesis and tumor progression, 
were chosen to estimate chronic, low-grade 
inflammation: CRP, TNF-α, and VEGF (13, 14). 
CRP was measured in both waves, while the other 
two biomarkers were only collected in W2 (58). 
Biospecimen collection, storage and processing 
have been previously described (58, 59,48). The 
coefficients of variation were considered within an 
acceptable range for all inflammatory markers 
(9.5% for CRP, 7.2% for TNF-α and 8.5% for 
VEGF). All inflammatory markers were natural 
log transformed to normalize their distributions. 
Covariates 
Confounders were selected from the 
literature and were measured in W1: age 
(continuous), gender (0=male (reference) vs. 
1=female), education (1=high school education or 
less vs. 0=some college or more (reference), 
marital status (0=married/cohabitating partner 
(reference) vs. 1=unmarried), race (0=non-
Hispanic (reference), 1=other), smoking 
(1=smoker vs. 0=non-smoker (reference), and CRP 
(continuous). Physical activity was classified as: 
low activity (e.g., exercise less than once a month), 
some activity (exercise at least once a month to 
less than twice a week), or frequent activity 
(exercise three or more times per week). Obesity 
was assessed with body mass index (BMI). Trained 
NSHAP interviewers objectively measured height 
and weight. Body mass index was derived from 
measured height and weight and was calculated as 
[(weight (lbs)/ height (in)
2
)*703] (77). Comorbid 
conditions were defined by a modified version of 
the Charlson Comorbidity Index (7). Individuals 
who  reported any of the following conditions were 
assigned one point for each condition: 
hypertension, heart condition (including: heart 
attack/myocardial infarction, congestive heart 
failure, stroke, or any procedure for coronary artery 
disease), diabetes, COPD/asthma, arthritis, 
Alzheimer‟s disease or dementia, and sensorimotor 
conditions (e.g., urinary or stool incontinence, or 
other urinary problems). Scores of the 11 questions 
were summed, for a total of 11 possible points. 
Functional impairment was measured using the 
Activities of Daily Living Scale (77) Scores were 
summed to represent higher levels of impairment 
in the path analysis. For the latent variable model 
each scale item was used to measure the 
underlying construct of physical disability. 
4. Statistical Analysis 
Means and standard deviations for 
continuous variables and proportions for 
categorical variables were calculated to compare 
cancer survivors to older adults without cancer on 
socio demographic, social support, mediator, and 
outcome variables. Simple linear regression was 
conducted to test differences between continuous 
variables and cancer survivors and older adults. 
Chi-square tests were used to test for differences in 
the proportions of categorical variables for cancer 
survivors and older adults. Pearson correlations 
were used to test preliminary correlations between 
depressive symptoms, social support, and 
inflammatory markers. 
Path analyses were used to test for group 
invariance because convergence problems were 
experienced with the latent variable model for the 
cancer group. First, each group was tested 
separately to determine if the model fit well for 
both groups using Hu & Bentler (1999)‟s criteria 
for satisfactory model fit: RMSEA ≤ 0.06, CFI ≥ 
0.95, and SRMR ≤ 0.08 (85). Improvements in 
model fit often take many forms, but the present 
study only focused on adding a residual covariance 
if it was theoretically plausible and substantial 
enough that over-fitting (and possibly chance 
covariation) did not occur. 
We additionally conducted a latent 
variable model with the total sample because latent 
models have the ability to parcel out measurement 
error (68). SEM testing proceeded in two phases: a 
measurement phase and a structural phase (68). In 
the measurement phase, we estimated the construct 
reliability using coefficient H (68), which was 
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considered acceptable for all factors (Social 
Support W1= 0.95, Social support W2= 0.95, 
Functional Impairment W1= 0.85, Depressive 
symptoms W1= 0.81, Depressive symptoms W2= 
0.80). In the initial measurement phase, a 
confirmatory factor analysis (CFA) model was 
imposed on the variance-covariance matrix in 
which all latent variables and standalone manifest 
variables were allowed to covary. This method 
ensures that any badness of fit in the model is the 
result of measurement model misspecification, 
rather than structural relations among the latent 
variables. Similar to the path model, the 
measurement model was evaluated to determine if 
improvements in model fit could be made. 
Modification indices were used to determine if 
meaningful improvements from residual 
covariances could be added to improve the initial 
model fit. Theoretically plausible modifications 
were made in a sequential fashion starting with the 
modification that would provide the largest drop in 
chi-square value. Once a modification was 
incorporated, the model was re-estimated and new 
modifications were reviewed. Direct and indirect 
effects were estimated for the structural model and 
are reported in SAS version 9.3 (SAS Inc., Cary, 
NC) was used to test distributional assumptions 
and calculate descriptive statistics and Mplus 
version 7 (Muthén & Muthén, Los Angeles, CA) 
was used to conduct SEM. 
Results 
Correlations between social support, 
inflammation, and depressive symptoms are 
reported in Table 1. Depressive symptoms were 
moderately correlated across waves  
(r=0.55, p<0.05). Depressive symptoms in 
W2 was weakly correlated with social support in 
W1 (r=-0.21, p<0.05), social support in W2 (r=-
0.25, p<0.05), CRP in W1 (r=0.14, p<0.05), CRP 
in W2 (r=0.12, p<0.05), and TNF-α in W2 (r=0.13, 
p<0.05). Social support in W2 was weakly, but 
positively correlated with TNF-α in W2 (r=0.14, 
p<0.05), CRP W1 (r=0.10, p<0.05), and CRP in 
W2 (r=0.08, p<0.05). 
The hypothesized path model fit well for 
each group, albeit a low CFI for the cancer 
survivors (Cancer survivors: RMSEA= 0.05, 
CFI=0.93, SRMR=0.04; Older adults: 
RMSEA=0.03, CFI=0.98, SRMR=0.02). No 
theoretically plausible misspecifications were 
identified for each group. Configural invariance 
was estimated by testing the model for both groups 
simultaneously. The model fit well and the 
modification indices did not indicate significant 
misspecification (RMSEA= 0.03, CFI=0.98, 
SRMR=0.02). More social support in W2 was 
directly associated with less depressive symptoms 
in W2 for older adults (estimate= -0.12, p<0.01). 
Social support in W1 was associated with VEGF in 
W2 among older adults (estimate=-0.10, p=0.04). 
TNF-α was  positively associated with 
depressive symptoms among cancer survivors 
(estimate=0.18, p=0.02). 
 
Table 1. Correlations among depressive symptoms and inflammation in Wave 2 (n=698) 
 
Finally, path invariance was tested by constraining all paths to be equal across groups. The p-value was 
not statistically significant, indicating that a significant amount of badness of fit was not introduced into the 
model when constraining the parameters to be equal across groups (scaled χ2=66.81, df= 54, p=0.1132), 
indicating that these groups did not differ and was considered the final model. The final path model fit well 
(RMSEA= 0.03, CFI= 0.97, SRMR=0.03) and is presented in Figure 3. No mediation effects were observed 
between social support, inflammation and depression Social support in W2 was significantly associated with 
depressive symptoms (estimate= - 0.11, p=0.01). 
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Figure 2. Standardized results from the path analysis for cancer survivors and older adults prior to constraining 
paths to be equal 
Final path model for cancer survivors and older adults. All parameters are free to vary across groups. 
Controlling for BMI, CRP, age, race, gender, education level, marital status, smoking status, physical activity, 
and functional impairment in Wave 1. Estimates are standardized and presented as cancer survivor/ older adults. 
*denotes p<0.05 
 For the latent variable model, the initial measurement model fit well despite a low CFI, 
(RMSEA=0.03, CFI=0.92, SRMR=0.05) but the modification indices suggested three plausible modifications: a 
covariance between the indicator for social support “rely on spouse” and the CES-D indicator “felt lonely” in 
W1 and W2, and a covariance between the CES-D indicator “could not get going” and the functional 
impairment indicator “getting dressed” in W1. After incorporating the final modifications we assessed the 
model fit. The model fit well (RMSEA ≤ 0.06 and SRMR ≤ 0.08), except in terms of the CFI (O). Next, items 
measured at two time points were constrained to be equal to each other. The scaled chi-square indicated that 
constraining the items to be equal across time points did not introduce a significant amount of badness of fit 
(scaled χ2=21.71, df= 15, p=0.1156) and was considered our final measurement model (RMSEA=0.03, 
CFI=0.92, and SRMR=0.05).  
Table 2. Standardized estimated direct and indirect effects for the path models  
From Social Support W2 to Depression W2 
  -0.07 0.61 -0.12 <0.01 -0.11 0.01 -0.24 0.03 
Total effect 
Total indirect effect 
  
0.03 
 
0.36 
 
0.00 
 
0.99 
 
0.00 
 
0.82 
 
0.00 
 
0.64 
Direct Effect 
Social Support W2  
Depression W2 
  
0.11 
 
0.42 
 
0.12 
 
<0.01 
 
-0.11 
 
0.01 
 
-0.25 
 
0.03 
Social Support W2 
CRP W2  
Depression 
W2 
0.00 0.99 0.00 0.66 0.00 0.58 0.00 0.82 
Social Support W2 
TNF-α  
Depression 
W2 
0.02 0.35 0.00 0.70 0.00 0.57 0.00 0.99 
Social Support W2 
VEGF  
Depression 
W2 
0.01 0.59 0.00 0.80 0.00 0.97 0.00 0.56 
   *Bold indicates p<0.05 
Next, the hypothesized structural model 
was estimated using the modifications from the 
final measurement model. Specifically, 
hypothesized direct and indirect paths were 
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modeled from social support in W1 and W2 to 
each inflammatory marker in W2, and depressive 
symptoms in W2. The final structural model fit 
well, except in terms of CFI (RMSEA=0.03, 
CFI=0.92, and SRMR=0.05). The results of the 
latent variable model for the total sample were 
similar to the constrained path analysis, and 
supported a direct path from the factor social 
support in W2 to the factor depressive symptoms 
in W2 (estimate= -0.25, p=0.03) (Figure 4). No 
evidence of an indirect effect between social 
support, inflammation, and depressive symptoms 
was observed. 
Discussion 
The current study is one of few to 
investigate intermediate inflammatory pathways 
using two social support frameworks. Our study 
provides support for a main effects hypothesis, 
whereby social support directly influences 
depressive symptoms, and provides little evidence 
for the stress buffering hypothesis. 
Consistent with other studies that support 
a direct relationship between social support and 
depressive symptomatology (66,77), our study 
demonstrated that a constrained path model fit the 
data well, indicating no group differences between 
cancer survivors and older adults. Additionally, we 
observed an inverse relationship, meaning that 
higher total support was associated with lower 
depressive symptoms, while controlling for a 
number of known confounding factors, such as 
sociodemographic factors, smoking status, physical 
activity, functional impairment, and multiple 
comorbidities. 
Although social science researchers 
hypothesize that chronic inflammation is a key 
pathway by which social support influences 
chronic disease outcomes, we found no empirical 
evidence for an intermediate link, whereby higher 
levels of social support lead to lower levels of 
chronic inflammation, which in turn leads to a 
lower occurrence of depressive symptoms. 
Moreover, these relationships were similar across 
groups, suggesting that social support directly 
influences depressive outcomes, regardless of 
facing a major stressful life experience, like cancer. 
 
Figure 4. Structural model depicting relationships between factors and observed variables  
 
Controlling for BMI, CRP, age, race, gender, 
education level, marital status, smoking status, 
physical activity, and functional impairment in 
Wave 1. Estimates are standardized. Covariances 
and residuals are not depicted for simplicity. 
*denotes p<0.05 
We only identified one study that tested 
inflammation as a mediator among cancer 
survivors. Hughes et al. (2014) showed that breast 
cancer patients with lower pre- treatment social 
support had higher IL-6 concentrations over time, 
and that higher levels of IL-6 predicted marginally 
larger increases in depressive symptoms (35). The 
differences in the results may be due to the use of 
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clinical samples versus population based samples 
and the inflammatory measures used. Additionally, 
we simultaneously tested these interrelationships 
using robust a SEM framework. Support for a main 
effects model may suggest that interactions with 
network members directly influence emotional 
states (86,87) and that the perception of lower 
support is detrimental to psychosocial functioning, 
regardless of experiencing a stressful event. In a 
meta-analysis, Mitchell and colleagues 
demonstrated that the pooled risk of depressive 
symptoms in long-term survivors was similar to 
their spouses, which may suggest transmission of 
depressive symptoms between partners (prevalence 
in cancer survivors= 26.7% versus 26.3%, 
RR=1.01 (95% CI: 0.86–1.20; p=0.88) through 
shared maladaptive behaviors or coping strategies, 
and/or lower resources that contribute to poor 
psychosocial outcomes (88). 
However, not all stressful events are 
perceived equally and may be individual and 
context specific. Therefore, some cancer survivors 
may be more resilient to life stress (89). It should 
also be noted that socially supported individuals 
may be able to buffer stress by attenuating or 
preventing a stress response in the first place. The 
perception that others  will help them and provide 
resources in times of need may prevent a situation 
from being interpreted as highly stressful (64); 
however we had no way of measuring perception 
of the stress response. Additionally, we only tested 
depressive symptoms as the main outcome and 
other chronic or acute diseases may show more 
pronounced relationships that support the stress -
buffering hypothesis. For example, Kielcott-Glaser 
et al. (2005) showed that socially supportive 
interactions were associated with a stronger 
immune response and faster wound healing 
compared to those who reported conflict 
interactions (90). 
Our results, in accordance with other 
studies, highlight that increased social support can 
reduce depressive symptomatology for cancer 
survivors and the older adult population, in general 
(77). Both groups may benefit from network 
interventions that enhance perceived feelings of 
emotional and tangible support. Providers should 
screen older adults and cancer survivors for 
adequate social support in order to prevent the 
negative cascade of symptoms associated with 
depressive symptoms and other chronic diseases. 
Given the health relevance of inflammation and 
depressive symptoms, social support interventions 
may improve long-term health and quality of life. 
The goal of this study was to empirically 
test two leading social network hypotheses  over a 
five-year period using a two-group SEM framework 
with a large sample of older adults and multiple 
markers of inflammation. Despite these strengths, 
our study is not without limitations. First, the 11-
item Iowa short-form CES-D measures depressive 
symptoms, rather than a clinical diagnosis of 
depression and some researchers have argued that 
this scale measures psychological distress, rather 
than depressive symptoms (91,92). Second, the 
results may be due to reverse causality, given that 
individuals with depressive symptoms may have 
higher levels of circulating inflammation (90). 
However, other studies support a unidirectional, 
rather than bidirectional relationship between social 
support, inflammation, and depressive symptoms 
(35). Third, TNF-α and VEGF were only measured 
in W2 and failure to control for these variables at 
baseline may have caused residual confounding. 
Fourth, our cancer survivor sample was small and 
the model (or portions of the model) may have 
been underpowered. Fifth, the cancer survivors and 
older adults were similar in terms of network 
support and depressive symptoms, which may be 
attributed to the time since cancer diagnosis, since 
the majority of cancer survivors had been 
diagnosed more than 10 years prior to the start of 
the NSHAP study. Therefore, a better proxy for 
stressful life events should be considered. Future 
large-scale studies should investigate the 
interrelationships among recent cancer survivors 
(e.g., < five years from diagnosis) to determine if 
differences exist. Finally, our analytic sample had 
large amounts of missing data due to assay-related 
problems with the inflammatory markers. 
Sensitivity analyses demonstrated that those who 
were missing were healthier than those included in 
the analytic sample on factors such as smoking and 
physical activity, which are both associated with 
inflammatory levels (59,60). Therefore, the 
inclusion of unhealthier older adults in the analytic 
sample may have overestimated the true 
associations of interest. Future longitudinal studies 
with repeated biomarker measures are needed to 
verify our findings. Additionally, because of the 
strict exclusion criteria, our study may have limited 
generalizability outside of this population. 
5. Conclusion 
In conclusion, our analysis supports a 
main effects hypothesis whereby social support is 
associated with lower levels of depressive 
symptoms, irrespective of life events. The results 
do not support an intermediate mechanism 
whereby inflammation mediated the relationship 
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between social support and depressive symptoms. 
A better understanding of the physiological 
mechanisms underlying social influences on 
depressive symptomatology and cancer survival is 
needed to elucidate meaningful biomarkers for 
therapeutic agents, as well as psychosocial 
interventions to improve well-being in late life. 
Public health interventions should consider the 
direct benefits of enhancing network support for 
cancer survivors and older adults at risk for 
depressive symptoms. 
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